Lv4
790 积分 2022-07-19 加入
Integration of Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy into Model‐Informed Dose Selection in Oncology First‐in‐Human Study: A Case of Roblitinib (FGF401)
21天前
已完结
Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4
21天前
已完结
GUK1 activation is a metabolic liability in lung cancer
1个月前
已完结
IRE1α silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer
2个月前
已完结
Identification of M4205─A Highly Selective Inhibitor of KIT Mutations for Treatment of Unresectable Metastatic or Recurrent Gastrointestinal Stromal Tumors
2个月前
已完结
The Far Side of Resistance to RAS Inhibitors
3个月前
已完结
Dissecting eIF4E action in tumorigenesis
3个月前
已完结
The role of eIF4F-driven mRNA translation in regulating the tumour microenvironment
3个月前
已完结
The molecular basis of translation initiation and its regulation in eukaryotes
3个月前
已完结
eIF4E – from translation to transformation
3个月前
已完结
皖公网安备34019202002308
